ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31

ATOSSA THERAPEUTICS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$2.56−0.35 (-12.03%)

Close on Oct 19, 2026

Market cap: $22.81M
P/E (TTM): –
Dividend yield: –

ATOSSA THERAPEUTICS, INC. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31
Depreciation & Amortization	–	–	–	0.01	0.02	0.05	0.05	0.04	0.13	0.30	0.27	0.48	0.47	0.13	0.02
Stock-Based Compensation	2.65	2.29	4.62	6.79	5.27	3.02	7.10	1.05	0.79	0.88	0.84	0.56	1.44	0.12	0.14
Change in Accounts Receivable	–	–	–	–	–	–	–	–	–	–	0	0.00	-0.35	-0.14	0.00
Change in Inventory	–	–	–	–	–	–	–	–	–	–	0.01	-0.01	-0.15	-0.03	0.09
Change in Accounts Payable	3.61	-0.13	-2.16	1.25	0.13	1.30	-0.06	0.02	0.08	-0.56	0.30	0.26	-0.06	0.00	0.06
Operating Cash Flow	-30	-21	-21	-21	-16	-12	-9.13	-8.96	-6.59	-5.37	-14	-11	-8.83	-3.90	-3.49
Capital Expenditures	-0.02	-0.02	-0.01	-0.03	-0.01	-0.01	-0.01	-0.11	–	–	–	–	–	–	–
Investing Cash Flow	-0.02	-0.02	-0.01	-4.73	-0.01	-0.01	-0.01	-0.11	–	-0.01	-0.29	-0.34	-0.49	-0.13	-0.14
Share Repurchases	–	0	-1.48	0	–	–	–	–	–	–	–	–	–	–	–
Stock Issued	–	–	–	–	–	–	–	–	6.16	4.70	9.46	13	–	–	–
Taxes Paid on Share-Based Awards	–	–	–	0	-0.57	-0.01	–	–	–	–	–	–	–	–	–
Financing Cash Flow	0	3.67	-1.48	0	113	39	11	12	11	4.70	9.46	13	14	3.85	5.53
Net Change in Cash	-30	-17	-22	-25	97	27	2.20	3.22	4.19	-0.69	-4.78	2.16	4.62	-0.19	1.90
Free Cash Flow	-30	-21	-21	-21	-16	-12	-9.14	-9.07	–	–	–	–	–	–	–
Income Taxes Paid	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0
Interest Paid	–	–	–	–	–	–	–	–	0.00	–	0.00	0.02	0.00	0.01	0.02

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -62.7%

Financial strength

Current ratio: 5.69
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 478.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.85
Dividend yield: –